A new laboratory method allows researchers to create compartments within a liquid that, like drops of oil in water, are separate but have no physical barrier between them. The method could help researchers understand how human cells use similar “membraneless compartments” to segregate and concentrate components for important cellular processes, chemical reactions, or other biological functions.

For a number of conditions like blood-related cancers, solid malignancies, pregnancy-related complications, transplant surgery, supportive care in cardiovascular surgery, injury-related trauma, and severe anemia, transfusion of red blood cells (RBCs) is a life-saving treatment.

A French startup has received a CE mark for a small, inflatable device designed to apply gentle pressure and halt nosebleeds.

Thirty years ago, when the field of tissue engineering beginning to coalesce, experts predicted we were just a couple decades away from creating brand-new organs for patients. After all, replacement parts made of plastic or metal had become a reality—just ask the millions of people living with knee or hip replacements.

Virtual Reality for Designing Drugs – University of Bristol Researchers

The second HIV infected person cured

Bacteria May Cause Diabetes 2 – Says, Scientists

CRISPR-Cas12b for Plant Genome Engineering

A team of researchers at the University of Minnesota Medical School recently proved the ability to grow human-derived blood vessels in a pig–a novel approach that has the potential for providing unlimited human vessels for transplant purposes. Because these vessels were made with patient-derived skin cells, they are less likely to be rejected by the recipient, helping patients potentially avoid the need for life-long, anti-rejection drugs.

Non-small cell lung cancer (NSCLC) is the most commonly diagnosed cancer, and the leading cause of cancer death worldwide. More than half of NSCLC patients die after developing metastases. There are no tests currently that would allow doctors to identify patients where more aggressive therapy could reduce mortality. Researchers at Tulane University have identified a protein on tumor-derived extracellular vesicles that indicates if a NSCLC tumor is likely to metastasize, according to a new study in Science Advances.